Pr François Ghiringhelli

Specialty

Oncologist, digestive expert

Hospital

Centre Georges-François Leclerc (Dijon)

Latest articles

• Surrogate markers of intestinal dysfunction associated with survival in advanced cancers. (Dec 1, 2025)
• The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs. (May 1, 2025)
• Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation. (Apr 29, 2025)
• NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate. (Apr 10, 2025)
• Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies. (Mar 6, 2025)